Annual EBITDA
-$12.33 M
+$5.57 M+31.11%
March 31, 2023
Summary
- As of March 1, 2025, MDNA annual EBITDA is -$12.33 million, with the most recent change of +$5.57 million (+31.11%) on March 31, 2023.
- During the last 3 years, MDNA annual EBITDA has fallen by -$6.13 million (-99.02%).
Performance
MDNA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$3.31 M
-$1.12 M-50.98%
June 30, 2023
Summary
- As of March 1, 2025, MDNA quarterly EBITDA is -$3.31 million, with the most recent change of -$1.12 million (-50.98%) on June 30, 2023.
- Over the past year, MDNA quarterly EBITDA has increased by +$74.40 thousand (+2.20%).
Performance
MDNA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$12.25 M
+$74.40 K+0.60%
June 30, 2023
Summary
- As of March 1, 2025, MDNA TTM EBITDA is -$12.25 million, with the most recent change of +$74.40 thousand (+0.60%) on June 30, 2023.
- Over the past year, MDNA TTM EBITDA has increased by +$4.00 million (+24.61%).
Performance
MDNA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MDNA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +31.1% | +2.2% | +24.6% |
| 3 y3 years | -99.0% | -81.2% | -73.6% |
| 5 y5 years | -112.9% | -308.1% | -144.3% |
MDNA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.2% | +51.0% | +17.0% | at high | +62.8% |
| 5 y | 5-year | +242.7% | +45.2% | +82.4% | +97.0% | +144.3% | +64.2% |
| alltime | all time | +1112.2% | +45.2% | >+9999.0% | +97.0% | >+9999.0% | +64.2% |
Medicenna Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$3.31 M(+51.0%) | -$12.25 M(-0.6%) |
| Mar 2023 | -$12.33 M(-31.1%) | -$2.20 M(-39.4%) | -$12.33 M(-2.1%) |
| Dec 2022 | - | -$3.62 M(+15.9%) | -$12.59 M(-2.0%) |
| Sep 2022 | - | -$3.12 M(-7.8%) | -$12.85 M(-20.9%) |
| Jun 2022 | - | -$3.39 M(+37.7%) | -$16.26 M(-9.3%) |
| Mar 2022 | -$17.89 M(+36.2%) | -$2.46 M(-36.5%) | -$17.92 M(-10.2%) |
| Dec 2021 | - | -$3.88 M(-40.6%) | -$19.96 M(-0.8%) |
| Sep 2021 | - | -$6.53 M(+29.2%) | -$20.12 M(+22.1%) |
| Jun 2021 | - | -$5.05 M(+12.4%) | -$16.48 M(+24.3%) |
| Mar 2021 | -$13.14 M(+112.1%) | -$4.50 M(+11.3%) | -$13.26 M(+23.4%) |
| Dec 2020 | - | -$4.04 M(+39.5%) | -$10.75 M(+26.1%) |
| Sep 2020 | - | -$2.89 M(+58.3%) | -$8.52 M(+20.7%) |
| Jun 2020 | - | -$1.83 M(-7.9%) | -$7.06 M(+14.0%) |
| Mar 2020 | -$6.19 M | -$1.98 M(+9.2%) | -$6.19 M(+23.5%) |
| Dec 2019 | - | -$1.82 M(+27.1%) | -$5.02 M(+11.6%) |
| Sep 2019 | - | -$1.43 M(+48.4%) | -$4.49 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$963.00 K(+19.3%) | -$3.74 M(+4.2%) |
| Mar 2019 | -$3.60 M(-37.9%) | -$807.30 K(-37.6%) | -$3.59 M(-5.9%) |
| Dec 2018 | - | -$1.29 M(+90.7%) | -$3.82 M(-9.8%) |
| Sep 2018 | - | -$678.80 K(-16.4%) | -$4.23 M(-13.8%) |
| Jun 2018 | - | -$812.00 K(-21.3%) | -$4.91 M(-14.8%) |
| Mar 2018 | -$5.79 M(-1.2%) | -$1.03 M(-39.7%) | -$5.76 M(-28.6%) |
| Dec 2017 | - | -$1.71 M(+26.0%) | -$8.07 M(+1.0%) |
| Sep 2017 | - | -$1.36 M(-18.5%) | -$7.99 M(+20.4%) |
| Jun 2017 | - | -$1.66 M(-50.2%) | -$6.64 M(+33.2%) |
| Mar 2017 | -$5.86 M(+476.1%) | -$3.34 M(+104.8%) | -$4.98 M(+202.0%) |
| Dec 2016 | - | -$1.63 M(>+9900.0%) | -$1.65 M(+8405.2%) |
| Sep 2016 | - | -$4700.00(-43.4%) | -$19.40 K(-85.2%) |
| Jun 2016 | - | -$8300.00(+29.7%) | -$131.40 K(-2.7%) |
| Mar 2016 | -$1.02 M | -$6400.00(-94.5%) | -$135.10 K(+5.0%) |
| Sep 2015 | - | -$116.70 K(+872.5%) | -$128.70 K(+972.5%) |
| Jun 2015 | - | -$12.00 K | -$12.00 K |
FAQ
- What is Medicenna Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Medicenna Therapeutics?
- What is Medicenna Therapeutics annual EBITDA year-on-year change?
- What is Medicenna Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Medicenna Therapeutics?
- What is Medicenna Therapeutics quarterly EBITDA year-on-year change?
- What is Medicenna Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Medicenna Therapeutics?
- What is Medicenna Therapeutics TTM EBITDA year-on-year change?
What is Medicenna Therapeutics annual EBITDA?
The current annual EBITDA of MDNA is -$12.33 M
What is the all time high annual EBITDA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high annual EBITDA is -$1.02 M
What is Medicenna Therapeutics annual EBITDA year-on-year change?
Over the past year, MDNA annual EBITDA has changed by +$5.57 M (+31.11%)
What is Medicenna Therapeutics quarterly EBITDA?
The current quarterly EBITDA of MDNA is -$3.31 M
What is the all time high quarterly EBITDA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high quarterly EBITDA is -$4700.00
What is Medicenna Therapeutics quarterly EBITDA year-on-year change?
Over the past year, MDNA quarterly EBITDA has changed by +$74.40 K (+2.20%)
What is Medicenna Therapeutics TTM EBITDA?
The current TTM EBITDA of MDNA is -$12.25 M
What is the all time high TTM EBITDA for Medicenna Therapeutics?
Medicenna Therapeutics all-time high TTM EBITDA is -$12.00 K
What is Medicenna Therapeutics TTM EBITDA year-on-year change?
Over the past year, MDNA TTM EBITDA has changed by +$4.00 M (+24.61%)